Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1862, Issue 9, 2016, Pages 1617-1627

  Kumar, Subodh ^a   Reddy, P Hemachandra ^a,b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Biomarker; Cerebral spinal fluid; Circulatory microRNA; CSF; Plasma; Serum

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 125B; MICRORNA 146A; MICRORNA 181B; MICRORNA 181C; MICRORNA 191-5P; MICRORNA 34A; MICRORNA 9; MICRORNA LET 7G-5P; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; AREA UNDER THE CURVE; CELL FUNCTION; CEREBROSPINAL FLUID; EXOSOME; EXTRACELLULAR FLUID; GENE EXPRESSION; HUMAN; HUNTINGTON CHOREA; MILD COGNITIVE IMPAIRMENT; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PLASMA; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REVIEW; RNA SYNTHESIS; SERUM;

EID: 84975060924     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2016.06.001     Document Type: Review

References (102)

1. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism and function. Cell 2004, 116:281-297.
2. Hooten N.N., Fitzpatrick M., Wood W.H., De S., Ejiogu N., Zhang Y., Mattison J.A., Becker K.G., Zonderman A.B., Evans M.K. Age-related changes in microRNA levels in serum. Aging 2013, 5:725-740.
3. Zhang H., Yang H., Zhang C., Jing Y., Wang C., Liu C., Zhang R., Wang J., Zhang J., Zen K., Zhang C., Li D. Investigation of microRNA expression in human serum during the aging process. J. Gerontol. A Biol. Sci. Med. Sci. 2015, 70:102-109.
4. Li Y., Kowdley K.V. MicroRNAs in common human diseases. Geno. Proteo. Bioinfo. 2012, 10:246-253.
5. Schwarzenbach H., Nishida N., Calin G.A., Pantel K. Clinical relevance of circulating cell-free microRNAs in cancer. Nat. Rev. Clin. Oncol. 2014, 11:145-156.
6. Kumar S., Chawla Y.K., Ghosh S., Chakraborti A. Severity of hepatitis C virus (genotype-3) infection positively correlates with circulating microRNA-122 in patients sera. Dis. Markers 2014, 2014:435476.
7. Denk J., Boelmans K., Siegismund C., Lassner D., Arlt S., Jahn H. MicroRNA profiling of CSF reveals potential biomarkers to detect Alzheimer's disease. PLoS One 2015, 10.
8. Femminella G.D., Ferrara N., Rengo G. The emerging role of microRNAs in Alzheimer's disease. Front. Physiol. 2015, 6:1-5.
9. Harries L.W. MicroRNAs as mediator of the aging process. Gene 2014, 5:656-670.
10. Kawahara Y. Human diseases caused by germline and somatic abnormalities in microRNA and microRNA-related genes. Cong. Anomal. 2014, 54:12-21.
11. Machida T., Tomofuji T., Ekuni D., Maruyama T., Yoneda T., Kawabata Y., Mizuno H., Miyai H., Kunitomo M., Morita M. MicroRNAs in salivary exosomes as potential biomarkers of aging. Int. J. Mol. Sci. 2015, 16:21294-21309.
12. Creemers E.E., Tijsen A.J., Pinto Y.M. Circulating microRNAs novel biomarkers and extracellular communicators in cardiovascular disease?. Circ. Res. 2012, 110:483-495.
13. Grasso M., Piscopo P., Confaloni A., Denti M.A. Circulating miRNAs as biomarkers for neurodegenerative disorders. Molecules 2014, 19:6891-6910.
14. Jung H.J., Suh Y. Circulating miRNAs in aging and age related disease. J. Genet. Genom. 2014, 41:465-472.
15. Mao P., Manczak M., Calkins M.J., Truong Q., Reddy T.P., Reddy A.P., Shirendeb U., Lo H.-H., Rabinovitch P.S., Reddy P.H. Mitochondria-targeted catalase reduces abnormal APP processing, amyloid b production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension. Hum. Mol. Genet. 2012, 21:2973-2990.
16. Reddy P.H. Is the mitochondrial outer membrane protein VDAC1 therapeutic target for Alzheimer's disease?. Biochim. Biophys. Acta 2013, 1832:67-75.
17. World Alzheimer's Report The Global Impact of Dementia 2015.
18. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 2001, 81:741-766.
19. LaFerla F.M., Green K.N., Oddo S. Intracellular amyloid-β in Alzheimer's disease. Nat. Rev. Neuro. 2007, 8:449-509.
20. Swerdlow R.H. Pathogenesis of Alzheimer's disease. Clin. Interven. Aging 2007, 2:347-359.
21. Reddy P.H., Manczaka M., Maoa P., Calkinsa M.J., Reddy A.P., Shirendeba U. Amyloid-β and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline. J. Alzheimers Dis. 2010, 20:S499-S512.
22. Reddy P.H. Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease. Brain Res. 2011, 1415:136-148.
23. Kandimalla R., Reddy P.H. Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis. Biochim. Biophys. Acta 2016, 1862:814-828.
24. Kandimalla R., Vallamkondu J., Corgiat E.B., Gill K.D. Understanding aspects of aluminum exposure in Alzheimer's disease development. Brain Pathol. 2015, 10.1111/bpa.12333.
25. Kandimalla R.J.L., Prabhakar S., Wani W.Y., Kaushal A., Gupta N., Sharma D.R., Grover V.K., Bhardwaj N., Jain K., Gill K.D. CSF p-tau levels in the prediction of Alzheimer's disease. Biology Open 2013, 2:1119-1124.
26. Wu H.Z.Y., Ong K.L., Seeher K., Armstrong N.J., Thalamuthu A., Brodaty H., Sachdev P., Mather K. Circulating microRNAs as biomarkers of Alzheimer's disease: a systemic review. J. Alzheimers Dis. 2016, 49:755-766.
27. Zafari S., Backes C., Meese E., Keller A. Circulating biomarkers panels in Alzheimer's disease. Gerontology 2015, 61:497-503.
28. Pana Y., Liue R., Terpstrab E., Wangb Y., Qiaob F., Wang J., Tong Y., Pana B. Dysregulation and diagnostic potential of microRNA in Alzheimer's disease. J. Alzheimers Dis. 2016, 49:1-12.
29. Connerty P., Ahadi A., Hutvagner G. RNA binding proteins in the miRNA pathway. Int. J. Mol. Sci. 2016, 17:31.
30. Meijer H.A., Smith E.M., Bushell M. Regulation of miRNA strand selection: follow the leader?. Biochem. Soc. Trans. 2014, 42:1135-1140.
31. Zhu M.Y., Zhang W., Yang T. Diverse microRNAs with convergent functions regulate tumorigenesis. Oncol. Letters 2016, 11:915-920.
32. Nowak J.S., Michlewski G. miRNAs in development and pathogenesis of the nervous system. Biochem. Soc. Trans. 2013, 41:815-820.
33. Adlakha Y.K., Saini N. Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128. Mol. Cancer 2014, 13:33.
34. Shao N.Y., Hu H.Y., Yan Z., Xu Y., Hu H., Menzel C., Li N., Chen W., Khaitovich P. Comprehensive survey of human brain microRNA by deep sequencing. BMC Genomics 2010, 11:4.
35. Juhila J., Sipila T., Icay K., Nicorici D., Ellonen P., Kallio A., Korpelainen E., Greco D., Hovatta I. MicroRNA expression profiling reveals miRNA families regulating specific biological pathways in mouse frontal cortex and hippocampus. PLoS One 2011, 6.
36. Turchinovich A., Samatov T.R., Tonevitsky A.G., Burwinkel B. Circulating miRNAs: cell-cell- communication function?. Front. Genet. 2013, 4:119.
37. Arroyoa J.D., Chevilleta J.R., Kroha E.M., Rufa I.K., Pritchardb C.C., Gibsonb D.F., Mitchella P.S., Bennetta C.F., Pogosova-Agadjanyand E.L., Stirewaltd D.L., Taitb J.F., Tewaria M. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. 2011, 108:365-373.
38. Vickers K.C., Palmisano B.T., Shoucri B.M., Shamburek R.D., Remaley A.T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 2011, 13:423-433.
39. Keller S., Sanderson M.P., Stoeck A., Altevogt P. Exosomes: from biogenesis and secretion to biological function. Immunol. Lett. 2006, 107:102-108.
40. Cheng L., Doecke J.D., Sharples R.A., Villemagne V.L., Fowler C.J., Rembach A., Martins R.N., Rowe C.C., Macaulay S.L., Masters C.L., Hill A.F. Prognostic serum miRNA biomarker associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment. Mol. Psychiatry 2014, 1-9.
41. Boon R.A., Vickers K.C. Intercellular transport of MicroRNAs. Arterioscler. Thromb. Vasc. Biol. 2013, 33:186-192.
42. Zhang Y., Liu D., Chen X., Li J., Li L., Bian Z., Sun F., Lu J., Yin Y., Cai X., Sun Q., Wang K., Ba Y., Wang Q., Wang D., Yang J., Liu P., Xu T., Yan Q., Zhang J., Zen K., Zhang C.Y. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell 2010, 39:133-144.
43. Zernecke A., Bidzhekov K., Noels H., Shagdarsuren E., Gan L., Denecke B., Hristov M., Köppel T., Jahantigh M.N., Lutgens E., Wang S., Olson E.N., Schober A., Weber C. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci. Signal. 2009, 2. (ra81).
44. Kosaka N., Iguchi H., Yoshioka Y., Takeshita F., Matsuki Y., Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 2010, 285:17442-17452.
45. Smith-Vikos T., Slack F.J. MicroRNAs circulate around Alzheimer disease. Genome Biol. 2013, 14:125.
46. Weber J.A., Baxter D.H., Zhang S., Huang D.Y., Huang K.H., Lee M.J., Galas D.J., Wang K. The microRNA spectrum in 12 body fluids. Clin. Chem. 2010, 56:1733-1741.
47. Igaz I., Igaz P. Diagnostic relevance of microRNAs in other body fluids including urine, feces, and saliva. EXS 2015, 106:245-252.
48. Zhou Q., Li M., Wang X., Li Q., Wang T., Zhu Q., Zhou X., Wang X., Gao X., Li X. Immune-related microRNAs are abundant in breast milk exosomes. Int. J. Biol. Sci. 2012, 8:118-123.
49. Park N.J., Zhou H., Elashoff D., Henson B.S., Kastratovic D.A., Abemayor E., Wong D.T. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin. Cancer Res. 2009, 15:5473-5477.
50. Momen-Heravi F., Trachtenberg A.J., Kuo W.P., Cheng Y.S. Genome wide study of salivary microRNAs for detection of oral cancer. JDR Clin. Res. Suppl. 2014, 93.
51. Shigehara K., Yokomuro S., Ishibashi O., Mizuguchi Y., Arima Y., Kawahigashi Y., Kanda T., Akagi I., Tajiri T., Yoshida H., Takizawa T., Uchida E. Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer. PLoS One 2011, 6.
52. Srivastava A., Goldberger H., Dimtchev A., Ramalinga M., Chijioke J., Marian C., Oermann E.K., Uhm S., Kim J.S., Chen L.N., Li X., Berry D.L., Kallakury B.V.S., Chauhan S.C., Collins S.P., Suy S., Kumar D. MicroRNA profiling in prostate cancer-the diagnostic potential of urinary miR-205 and miR-214. PLoS One 2013, 8.
53. Papadopoulos T., Belliere J., Bascands J.L., Neau E., Klein J., Schanstra J.P. miRNAs in urine: a mirror image of kidney disease?. Expert. Rev. Mol. Diagn. 2015, 15:361-374.
54. Stuopelyte˙ K., Daniūnaite˙ K., Jankevičius F., Jarmalaite˙ S. Detection of miRNAs in urine of prostate cancer patients. Medicina 2016, (Article in press).
55. Link A., Balaguer F., Shen Y., Nagasaka T., Lozano J.J., Boland C.R., Goel A. Fecal MicroRNAs as novel biomarkers for colon cancer screening. Cancer Epidemiol. Biomark. Prev. 2010, 19:1766-1774.
56. Link A., Becker V., Goel A., Wex T., Malfertheiner P. Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer. PLoS One 2012, 7.
57. He Y., Lin J., Kong D., Huang M., Xu C., Kim T.K., Etheridge A., Luo Y., Ding Y., Wang K. Current state of circulating microRNAs as cancer biomarkers. Clin. Chem. 2015, 61:1138-1155.
58. Ma R., Jiang T., Kang X. Circulating microRNAs in cancer: origin, function and application. J. Exp. Clin. Cancer Res. 2012, 31:38.
59. Yin Y., Cao Y., Xu Y., Li G. Colorimetric immunoassay for detection of tumor markers. Int. J. Mol. Sci. 2010, 11:5077-5094.
60. Khoury S., Tran N. Circulating microRNAs: potential biomarkers for common malignancies. Biomark. Med 2015, 9:131-151.
61. American Cancer Society Global Cancer Facts & Figures 2015, third ed.
62. Shen J., Liu J., Liu Z., Todd N.W., Zhang H., Liao J., Yu L., Guarnera M.A., Li R., Cai L., Zhan M., Jiang F. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer 2011, 11:374.
63. Shen J., Hruby G.W., McKiernan J.M., Gurvich I., Lipsky M.J., Benson M.C., Santella R.M. Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer. Prostate 2012, 72:1469-1477.
64. Kodahla A.R., Lyngc M.B., Binderd H., Colda S., Gravgaardc K., Knoope A.S., Ditze H.J. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study. Mol. Oncol. 2014, 8:874-883.
65. Sochor M., Basova P., Pesta M., Dusilkova N., Bartos J., Burda P., Pospisil V., Stopka T. Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum. BMC Cancer 2014, 14:448.
66. Zearo S., Kim E., Zhu Y., Zhao J.T., Sidhu S.B., Robinson B.G., Soon P.S.H. MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers. BMC Cancer 2014, 14:200.
67. Heneghan H.M., Miller N., Kelly R., Newell J., Kerin M.J. Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. Oncologist 2010, 15:673-682.
68. Jung E.J., Santarpia L., Kim J., Esteva F.J., Moretti E., Buzdar A.U., Leo A.D., Le X.F., Bast R.C., Park S.-T., Pusztai L., Calin G.A. Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients. Cancer 2012, 118:2603-2614.
69. Li W., Xie L., He X., Li J., Tu K., Wei L., Wu J., Guo Y., Ma X., Zhang P., Pan Z., Hu X., Zhao Y., Xie H., Jiang G., Chen T., Wang J., Zheng S., Cheng J., Wan D., Yang S., Li Y., Gu J. Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma. Int. J. Cancer 2008, 123:1616-1622.
70. Qi P., Cheng S.Q., Wang H., Li N., Chen Y.F., Gao C.F. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One 2011, 6.
71. Giray B.G., Emekdas G., Tezcan S., Ulger M., Serin M.S., Sezgin O., Altintas E., Tiftik E.N. Profiles of serum microRNAs; miR-125b-5p and miR-223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma. Mol. Biol. Rep. 2014, 41:4513-4519.
72. Pu X.-X., Huang G.-L., Guo H.-Q., Guo C.-C., Li H., Ye S., Ling S., Jiang L., Tian Y., Lin T.-Y. Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J. Gastroenterol. Hepatol. 2010, 25:1674-1680.
73. Shivapurkar N., Weiner L.M., Marshall J.L., Madhavan S., Mays A.D., Juhl H., Wellstein A. Recurrence of early stage colon cancer predicted by expression pattern of circulating microRNAs. PLoS One 2014, 9.
74. Zanutto S., Pizzamiglio S., Ghilotti M., Bertan C., Ravagnani F., Perrone F., Leo E., Pilotti S., Verderio P., Gariboldi M., Pierotti M.A. Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer. Br. J. Cancer 2014, 110:1001-1007.
75. Reddy P.H. Mitochondrial medicine for aging and neurodegenerative diseases. NeuroMolecular Med. 2008, 10:291-315.
76. Margis R., Rieder C.R. Identification of blood miRNAs associated to Parkinson's disease. J. Biotechnol. 2011, 152:96-101.
77. Cardo L.F., Coto E., de Mena L., Ribacoba R., Moris G., Mene'ndez M., Alvarez V. Profile of microRNAs in the plasma of Parkinson's disease patients and healthy controls. J. Neurol. 2013, 260:1420-1422.
78. Botta-Orfila T., Morató X., Compta Y., Lozano J.J., Falgàs N., Valldeoriola F., Pont-Sunyer C., Vilas D., Mengual L., Fernández M., Molinuevo J.L., Antonell A., Martí M.J., Fernández-Santiago R., Ezquerra M. Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease. J. Neurosci. Res. 2014, 92:1071-1077.
79. Toivonen J.M., Manzano R., Oliva'n S., Zaragoza P., Garci'a-Redondo A., Osta R. MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis. PLoS One 2014, 92:e89065.
80. Takahashi I., Hama Y., Matsushima M., Hirotani M., Kano T., Hohzen H., Yabe I., Utsumi J., Sasaki H. Identification of plasma microRNAs as a biomarker of sporadic amyotrophic lateral sclerosis. Mol. Brain 2015, 8:67.
81. Satoh J., Kino Y., Niida S. MicroRNA-Seq data analysis pipeline to identify blood biomarkers for Alzheimer's disease from public data. Biomark. Insights 2015, 10:21-31.
82. Schipper H.M., Maes O.C., Chertkow H.M., Wang E. microRNA expression in Alzheimer blood mononuclear cells. Gene Regul. Syst. Biol. 2007, 1:263-274.
83. Geekiyanage H., Jicha G.A., Nelson P.T., Chan C. Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease. Exp. Neurol. 2012, 235:491-496.
84. Galimberti D., Villa C., Fenoglio C., Serpente M., Ghezzi L., Cioffi S.M.G., Arighi A., Fumagalli G., Scarpini E. Circulating miRNAs as potential biomarkers in Alzheimer's disease. J. Alzheimers Dis. 2014, 42:1261-1267.
85. Tan L., Yu J.T., Tan M.S., Liu Q.Y., Wang H.F., Zhang W. Circulating miR-125 as a biomarker of Alzheimer's disease. J. Neurol. Sci. 2014, 336:52-56.
86. Tan L., Yu J.T., Tan M.S., Liu Q.Y., Wang H.F., Zhang W., Jiang T., Tan L. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease. J. Alzheimers Dis. 2014, 40:1017-1027.
87. Dong H., Li J., Huang L., Chen X., Li D., Wang T., Hu C., Xu J., Zhang C., Zen K., Xiao S., Yan Q., Wang C., Zhang C.-Y. Serum microRNA profiles serve as novel biomarkers for the diagnosis of Alzheimer's disease. Dis. Markers 2015, 2015:625659.
88. Kumar P., Dezso Z., MacKenzie C., Oestreicher J., Agoulnik S., Byrne M., Bernier F., Yanagimachi M., Aoshima K., Oda Y. Circulating miRNA biomarkers for Alzheimer's disease. PLoS One 2013, 8.
89. Lugli G., Cohen A.M., Bennett D.A., Shah R.C., Fields C.J., Hernandez A.G., Smalheiser N.R. Plasma exosomal miRNAs in persons with and without Alzheimer disease: altered expression and prospects for biomarkers. PLoS One 2015, 10.
90. Alexandrov P.N., Dua P., Hill J.M., Bhattacharjee S., Zhao Y., Lukiw W.J. microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). Int. J. Biochem. Mol. Biol. 2012, 3:365-373.
91. Zhang L., Dong L.Y., Li Y.J., Hong Z., Wei W.S. The microRNA miR-181c controls microglia-mediated neuronal apoptosis by suppressing tumor necrosis factor. J. Neuroinflammation 2012, 9:211.
92. Coolen M., Katz S., Bally-Cuif L. miR-9: a versatile regulator of neurogenesis. Front. Cell. Neurosci. 2013, 7:220.
93. Rusca N., Monticelli S. MiR-146a in immunity and disease. Mol. Biol. Int. 2011, 2011:437301.
94. Boyerinas B., Park S.M., Hau A., Murmann A.E., Peter M.E. The role of let-7 in cell differentiation and cancer. Endocr. Relat. Cancer 2010, 17:F19-F36.
95. Sun Y.M., Lin K.Y., Chen Y.Q. Diverse functions of miR-125 family in different cell contexts. J. Hematol. Oncol. 2013, 6:6.
96. Nagpal N., Kulshreshtha R. miR-191: an emerging player in disease biology. Front. Genet. 2014, 5:99.
97. Lukiw W.J. Variability in micro RNA (miRNA) abundance, speciation and complexity amongst different human populations and potential relevance to Alzheimer's disease (AD). Front. Cell. Neurosci. 2013, 27:133.
98. Hulse A.M., Cai J.J. Genetic variants contribute to gene expression variability in humans. Genetics 2013, 193:95-108.
99. Guire V.D., Robitaille R., Tetreault N., Guerin R., Menard C., Bambace N., Sapieha P. Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human disease: promises and challenges. Clin. Biochem. 2013, 46:846-860.
100. Courts C., Madea B. Micro-RNA-A potential for forensic science?. Forensic Sci. Int. 2010, 203:106-111.
101. Dumache R., Ciocan V., Muresan C., Rogobete A.F., Enache A. Circulating microRNAs as promising biomarkers in forensic body fluids identification. Clin. Lab. 2015, 61:1129-1135.
102. Wang Z., Zhang J., Luo H., Ye Y., Yan J., Hou Y. Screening and confirmation of microRNA markers for forensic body fluid identification. Forensic Sci. Int. Genet. 2013, 7:116-123.